SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

Market Cap	3.01B
Revenue (ttm)	975.68M
Net Income (ttm)	146.87M
Shares Out	n/a
EPS (ttm)	0.97
PE Ratio	20.51
Forward PE	18.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	26.65
Previous Close	26.65
Day's Range	26.65 - 26.65
52-Week Range	19.84 - 30.40
Beta	n/a
RSI	38.79
Earnings Date	Dec 11, 2025

About BIT:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. It offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT...

• Industry: Glass Containers
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SXP

Financial Performance

In 2024, BIT:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.